GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » Net Change in Cash

Angelalign Technology (HKSE:06699) Net Change in Cash : HK$-1,195 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Angelalign Technology's Net Change in Cash for the six months ended in Dec. 2024 was HK$675 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-1,195 Mil.

Angelalign Technology Net Change in Cash Historical Data

The historical data trend for Angelalign Technology's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Angelalign Technology Net Change in Cash Chart

Angelalign Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Change in Cash
Get a 7-Day Free Trial 442.43 3,364.02 25.27 -1,126.60 -1,186.46

Angelalign Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.57 -670.65 -457.94 -1,870.03 674.80

Angelalign Technology Net Change in Cash Calculation

Angelalign Technology's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=131.503+-1079.142+-221.231+-17.591
=-1,186

Angelalign Technology's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=269.683+956.587+-529.796+-21.672
=675

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-1,195 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Angelalign Technology Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Angelalign Technology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » Net Change in Cash
Comparable Companies
HKSE:09997 HKSE:02276 HKSE:01501 HKSE:03600 HKSE:06929 HKSE:01358 HKSE:01120 HKSE:01947 HKSE:01406 HKSE:00876 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
AGLFF:USA 77D:Germany
Address
No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN
Website
https://www.angelalign.com
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Shore Lead Limited 2201 Interest of corporation controlled by you
Sky Honour Enterprises Limited 2101 Beneficial owner
Li Huamin 2307 Founder of a discretionary trust who can infl
Carecapital Ea, Inc 2201 Interest of corporation controlled by you
Carecapital Management Group Llc 2201 Interest of corporation controlled by you
Carecapital Moonstone Holdings Limited 2201 Interest of corporation controlled by you
Carecapital Dental Holdings Limited 2201 Interest of corporation controlled by you
Feng Dai 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you
Carecapital Orthotech Limited 2101 Beneficial owner
Chen Kai 2201 Interest of corporation controlled by you
Jovial Day Global Limited 2201 Interest of corporation controlled by you
Vast Luck Global Limited 2101 Beneficial owner
Xing Zheng Quan Qiu Ji Jin Guan Li You Xian Gong Si 2102 Investment manager

Angelalign Technology Headlines

No Headlines